SDR16C5 anticorps (Middle Region)

N° du produit ABIN954494

L’anticorps Lapin Polyclonal anti-SDR16C5 a été validé pour WB et EIA. Il convient pour détecter SDR16C5 dans des échantillons de Humain.

Aperçu rapide pour SDR16C5 anticorps (Middle Region) (ABIN954494)

Antigène: SDR16C5 (RDHE2) (Epidermal Retinal Dehydrogenase 2 (RDHE2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SDR16C5 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Détail du produit anti-SDR16C5 anticorps

Épitope: AA 122-151, Middle Region

Specificité: Recognizes SDR16C5 (Center).

Purification: Protein A column followed by peptide Affinity purification

Immunogène: KLH conjugated synthetic peptide between 122-151 amino acids from the Central region of Human SDR16C5. Genename: SDR16C5

Isotype: Ig Fraction

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) Sodium Azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur SDR16C5

Antigène: SDR16C5 (RDHE2) (Epidermal Retinal Dehydrogenase 2 (RDHE2))

Autre désignation: RDHE2 / SDR16C5

Sujet: RDHE2 belongs to a family of short-chain alcohol dehydrogenases/reductases that catalyze the first and rate-limiting step that generates retinaldehyde from retinol (Matsuzaka et al., 2002 [PubMed 12372410]).Synonyms: EPHD-2, Epidermal retinol dehydrogenase 2, RDH-E2, Retinal short-chain dehydrogenase reductase 2, Short-chain dehydrogenase/reductase family 16C member 5, retSDR2

ID gène: 195814

NCBI Accession: NP_620419